Global Allergic Conjunctivitis Market, Patients, Treated Patients, by Countries (India, China, Japan, US, UK, etc), Disease Type (SAC, PAC, VKC, AKC, GPC), Drugs Profile (Zerviate, OTX-DP, ADX-102, PRT-2761, etc) Companies, Growth Drivers & Challenges
Table of Contents
1. Executive Summary
2. Global Allergic Conjunctivitis Market and Patients Analysis
2.1 Allergic Conjunctivitis Market
2.2 Allergic Conjunctivitis Patient Numbers
2.3 Allergic Conjunctivitis Treated Patient Numbers
3. Share Analysis – Global Allergic Conjunctivitis
3.1 Country Market Share
3.2 Patients Population Share
3.3 Treated Patients Population Share
3.4 By Disease Type Share
4. India
4.1 Allergic Conjunctivitis Patient Numbers
4.2 Allergic Conjunctivitis Treated Patient Numbers
4.3 Allergic Conjunctivitis Market
5. China
5.1 Allergic Conjunctivitis Patient Numbers
5.2 Allergic Conjunctivitis Treated Patient Numbers
5.3 Allergic Conjunctivitis Market
6. Japan
6.1 Allergic Conjunctivitis Patient Numbers
6.2 Allergic Conjunctivitis Treated Patient Numbers
6.3 Allergic Conjunctivitis Market
7. United States
7.1 Allergic Conjunctivitis Patient Numbers
7.2 Allergic Conjunctivitis Treated Patient Numbers
7.3 Allergic Conjunctivitis Market
8. United Kingdom
8.1 Allergic Conjunctivitis Patient Numbers
8.2 Allergic Conjunctivitis Treated Patient Numbers
8.3 Allergic Conjunctivitis Market
9. France
9.1 Allergic Conjunctivitis Patient Numbers
9.2 Allergic Conjunctivitis Treated Patient Numbers
9.3 Allergic Conjunctivitis Market
10. Germany
10.1 Allergic Conjunctivitis Patient Numbers
10.2 Allergic Conjunctivitis Treated Patient Numbers
10.3 Allergic Conjunctivitis Market
11. Italy
11.1 Allergic Conjunctivitis Patient Numbers
11.2 Allergic Conjunctivitis Treated Patient Numbers
11.3 Allergic Conjunctivitis Market
12. Spain
12.1 Allergic Conjunctivitis Patient Numbers
12.2 Allergic Conjunctivitis Treated Patient Numbers
12.3 Allergic Conjunctivitis Market
13. Disease Type – Global Allergic Conjunctivitis Market
13.1 Seasonal Allergic Conjunctivitis (SAC) & Perennial Allergic Conjunctivitis (PAC)
13.2 Vernal Keratoconjunctivitis (VKC)
13.3 Atopic Keratoconjunctivitis (AKC)
13.4 Giant Papillary Conjunctivitis (GPC)
14. Global Allergic Conjunctivitis Drugs Profile/Pipe Line Drugs
14.1 Zerviate
14.2 OTX-DP (Dexamethasone Insert)
14.3 ADX-102
14.4 PRT2761
14.5 CVXL-0074
14.6 AK-002
14.7 Bertilimumab
14.8 Reproxalap
14.9 ST-266
14.10 SYL-116011
15. Growth Driver
15.1 Rapid Urbanization and Growth of Particulate Pollution
15.2 Increasing Ageing Population & Widespread Use of Medications for Various Eye Diseases
16. Challenges
16.1 Diagnostic Challenges
16.2 Undertreated by Patients
17. Santen Pharmaceutical
17.1 Company Overview
17.2 Initiatives
17.2.1 Point 1
17.2.2 Point 2
17.3 Financial Insight
18. Alcon Inc. (Novartis)
18.1 Company Overview
18.2 Initiatives
18.2.1 Point 1
18.2.2 Point 2
18.3 Financial Insight
19. Portola Pharmaceuticals Inc.
19.1 Company Overview
19.2 Initiatives
19.2.1 Point 1
19.2.2 Point 2
19.3 Financial Insight
20. Ocular Therapeutix Inc.
20.1 Company Overview
20.2 Initiatives
20.2.1 Point 1
20.2.2 Point 2
20.3 Financial Insight
List of Tables:
Table 3‑1: Global - Allergic Conjunctivitis Patients Population Country Share (Percent), 2013 – 2018
Table 3‑2: Global – Forecast for Allergic Conjunctivitis Patients Population Country Share (Percent), 2019 – 2025
List of Figures:
Figure 2‑1: Global - Allergic Conjunctivitis Market (Million US$), 2013 – 2018
Figure 2‑2: Global – Forecast for Allergic Conjunctivitis Market (Million US$), 2019 – 2025
Figure 2‑3: Global - Allergic Conjunctivitis Patient Numbers (Million), 2013 – 2018
Figure 2‑4: Global – Forecast for Allergic Conjunctivitis Patient Numbers (Million), 2019 – 2025
Figure 2‑5: Global - Allergic Conjunctivitis Treated Patient Numbers (Million), 2013 – 2018
Figure 2‑6: Global – Forecast for Allergic Conjunctivitis Treated Patient Numbers (Million), 2019 – 2025
Figure 3‑1: Global - Allergic Conjunctivitis Market Country Share (Percent), 2013 – 2018
Figure 3‑2: Global – Forecast for Allergic Conjunctivitis Market Country Share (Percent), 2019 – 2025
Figure 3‑3: Global - Allergic Conjunctivitis Treated Patients Population Country Share (Percent), 2013 – 2018
Figure 3‑4: Global – Forecast for Allergic Conjunctivitis Treated Patients Population Country Share (Percent), 2019 – 2025
Figure 3‑5: Global - Allergic Conjunctivitis Disease Type Market Share (Percent), 2013 – 2018
Figure 3‑6: Global – Forecast for Allergic Conjunctivitis Disease Type Market Share (Percent), 2019 – 2025
Figure 4‑1: India - Allergic Conjunctivitis Patient Numbers (Million), 2013 – 2018
Figure 4‑2: India – Forecast for Allergic Conjunctivitis Patient Numbers (Million), 2019 – 2025
Figure 4‑3: India - Allergic Conjunctivitis Treated Patient Numbers (Million), 2013 – 2018
Figure 4‑4: India – Forecast for Allergic Conjunctivitis Treated Patient Numbers (Million), 2019 – 2025
Figure 4‑5: India - Allergic Conjunctivitis Market (Million US$), 2013 – 2018
Figure 4‑6: India – Forecast for Allergic Conjunctivitis Market (Million US$), 2019 – 2025
Figure 5‑1: China - Allergic Conjunctivitis Patient Numbers (Million), 2013 – 2018
Figure 5‑2: China – Forecast for Allergic Conjunctivitis Patient Numbers (Million), 2019 – 2025
Figure 5‑3: China - Allergic Conjunctivitis Treated Patient Numbers (Million), 2013 – 2018
Figure 5‑4: China – Forecast for Allergic Conjunctivitis Treated Patient Numbers (Million), 2019 – 2025
Figure 5‑5: China - Allergic Conjunctivitis Market (Million US$), 2013 – 2018
Figure 5‑6: China – Forecast for Allergic Conjunctivitis Market (Million US$), 2019 – 2025
Figure 6‑1: Japan - Allergic Conjunctivitis Patient Numbers (Million), 2013 – 2018
Figure 6‑2: Japan – Forecast for Allergic Conjunctivitis Patient Numbers (Million), 2019 – 2025
Figure 6‑3: Japan - Allergic Conjunctivitis Treated Patient Numbers (Million), 2013 – 2018
Figure 6‑4: Japan – Forecast for Allergic Conjunctivitis Treated Patient Numbers (Million), 2019 – 2025
Figure 6‑5: Japan - Allergic Conjunctivitis Market (Million US$), 2013 – 2018
Figure 6‑6: Japan – Forecast for Allergic Conjunctivitis Market (Million US$), 2019 – 2025
Figure 7‑1: United States - Allergic Conjunctivitis Patient Numbers (Million), 2013 – 2018
Figure 7‑2: United States – Forecast for Allergic Conjunctivitis Patient Numbers (Million), 2019 – 2025
Figure 7‑3: United States - Allergic Conjunctivitis Treated Patient Numbers (Million), 2013 – 2018
Figure 7‑4: United States – Forecast for Allergic Conjunctivitis Treated Patient Numbers (Million), 2019 – 2025
Figure 7‑5: United States - Allergic Conjunctivitis Market (Million US$), 2013 – 2018
Figure 7‑6: United States – Forecast for Allergic Conjunctivitis Market (Million US$), 2019 – 2025
Figure 8‑1: United Kingdom - Allergic Conjunctivitis Patient Numbers (Million), 2013 – 2018
Figure 8‑2: United Kingdom – Forecast for Allergic Conjunctivitis Patient Numbers (Million), 2019 – 2025
Figure 8‑3: United Kingdom - Allergic Conjunctivitis Treated Patient Numbers (Million), 2013 – 2018
Figure 8‑4: United Kingdom – Forecast for Allergic Conjunctivitis Treated Patient Numbers (Million), 2019 – 2025
Figure 8‑5: United Kingdom - Allergic Conjunctivitis Market (Million US$), 2013 – 2018
Figure 8‑6: United Kingdom – Forecast for Allergic Conjunctivitis Market (Million US$), 2019 – 2025
Figure 9‑1: France - Allergic Conjunctivitis Patient Numbers (Million), 2013 – 2018
Figure 9‑2: France – Forecast for Allergic Conjunctivitis Patient Numbers (Million), 2019 – 2025
Figure 9‑3: France - Allergic Conjunctivitis Treated Patient Numbers (Million), 2013 – 2018
Figure 9‑4: France – Forecast for Allergic Conjunctivitis Treated Patient Numbers (Million), 2019 – 2025
Figure 9‑5: France - Allergic Conjunctivitis Market (Million US$), 2013 – 2018
Figure 9‑6: France – Forecast for Allergic Conjunctivitis Market (Million US$), 2019 – 2025
Figure 10‑1: Germany - Allergic Conjunctivitis Patient Numbers (Million), 2013 – 2018
Figure 10‑2: Germany – Forecast for Allergic Conjunctivitis Patient Numbers (Million), 2019 – 2025
Figure 10‑3: Germany - Allergic Conjunctivitis Patient Treated Numbers (Million), 2013 – 2018
Figure 10‑4: Germany – Forecast for Allergic Conjunctivitis Treated Patient Numbers (Million), 2019 – 2025
Figure 10‑5: Germany - Allergic Conjunctivitis Market (Million US$), 2013 – 2018
Figure 10‑6: Germany – Forecast for Allergic Conjunctivitis Market (Million US$), 2019 – 2025
Figure 11‑1: Italy - Allergic Conjunctivitis Patient Numbers (Million), 2013 – 2018
Figure 11‑2: Italy – Forecast for Allergic Conjunctivitis Patient Numbers (Million), 2019 – 2025
Figure 11‑3: Italy - Allergic Conjunctivitis Treated Patient Numbers (Million), 2013 – 2018
Figure 11‑4: Italy – Forecast for Allergic Conjunctivitis Treated Patient Numbers (Million), 2019 – 2025
Figure 11‑5: Italy - Allergic Conjunctivitis Market (Million US$), 2013 – 2018
Figure 11‑6: Italy – Forecast for Allergic Conjunctivitis Market (Million US$), 2019 – 2025
Figure 12‑1: Spain - Allergic Conjunctivitis Patient Numbers (Million), 2013 – 2018
Figure 12‑2: Spain – Forecast for Allergic Conjunctivitis Patient Numbers (Million), 2019 – 2025
Figure 12‑3: Spain - Allergic Conjunctivitis Treated Patient Numbers (Million), 2013 – 2018
Figure 12‑4: Spain – Forecast for Allergic Conjunctivitis Treated Patient Numbers (Million), 2019 – 2025
Figure 12‑5: Spain - Allergic Conjunctivitis Market (Million US$), 2013 – 2018
Figure 12‑6: Spain – Forecast for Allergic Conjunctivitis Market (Million US$), 2019 – 2025
Figure 13‑1: Global - Seasonal Allergic Conjunctivitis (SAC) & Perennial Allergic Conjunctivitis (PAC) Market (Million US$), 2013 – 2018
Figure 13‑2: Global – Forecast for Seasonal Allergic Conjunctivitis (SAC) & Perennial Allergic Conjunctivitis (PAC) Market (Million US$), 2019 – 2025
Figure 13‑3: Global - Vernal Keratoconjunctivitis (VKC) Market (Million US$), 2013 – 2018
Figure 13‑4: Global – Forecast for Vernal Keratoconjunctivitis (VKC) Market (Million US$), 2019 – 2025
Figure 13‑5: Global - Atopic Keratoconjunctivitis (AKC) Market (Million US$), 2013 – 2018
Figure 13‑6: Global – Forecast for Atopic Keratoconjunctivitis (AKC) Market (Million US$), 2019 – 2025
Figure 13‑7: Global - Giant Papillary Conjunctivitis (GPC) Market (Million US$), 2013 – 2018
Figure 13‑8: Global – Forecast for Giant Papillary Conjunctivitis (GPC) Market (Million US$), 2019 – 2025
Figure 14‑1: Allergic Conjunctivitis Pipe Line Drug – Zerviate Status (2018)
Figure 14‑2: Allergic Conjunctivitis Pipe Line Drug – OTX-DP (Dexamethasone Insert) Status (2018)
Figure 14‑3: Allergic Conjunctivitis Pipe Line Drug – ADX-102 Status (2018)
Figure 14‑4: Allergic Conjunctivitis Pipe Line Drug – PRT-2761Status (2018)
Figure 14‑5: Allergic Conjunctivitis Pipe Line Drug – CVXL-0074 Status (2018)
Figure 14‑6: Allergic Conjunctivitis Pipe Line Drug – AK-002 Status (2018)
Figure 14‑7: Allergic Conjunctivitis Pipe Line Drug – Bertilimumab Status (2018)
Figure 14‑8: Allergic Conjunctivitis Pipe Line Drug – Reproxalap Status (2018)
Figure 14‑9: Allergic Conjunctivitis Pipe Line Drug – ST-266 Status (2018)
Figure 14‑10: Allergic Conjunctivitis Pipe Line Drug – SYL-116011 Status (2018)
Figure 17‑1: Santen Pharmaceutical – Global Revenue (Million US$), 2014 - 2018
Figure 17‑2: Santen Pharmaceutical – Forecast for Global Revenue (Million US$), 2019 - 2025
Figure 18‑1: Alcon (Novartis) – Global Revenue (Million US$), 2014 - 2018
Figure 18‑2: Alcon (Novartis) – Forecast for Global Revenue (Million US$), 2019 - 2025
Figure 19‑1: Portola Pharmaceuticals – Global Revenue (Thousand US$), 2014 - 2018
Figure 19‑2: Portola Pharmaceuticals – Forecast for Global Revenue (Thousand US$), 2019 - 2025
Figure 20‑1: Ocular Therapeutix – Global Revenue (Thousand US$), 2014 - 2018
Figure 20‑2: Ocular Therapeutix – Forecast for Global Revenue (Thousand US$), 2019 - 2025
Global Antioxidant Vitamins Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 100
The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030.
North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030.
Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......
Global Clavulanate Potassium Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 86
The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030.
North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030.
Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......
Global Amoxicillin Sodium Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 84
The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030.
North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030.
Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......
Global Melatonin Supplements Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 106
The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030.
North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030.
Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......
Global Sleeping Pills (Prescription Drugs) Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 93
The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......
Global Sleeping Pills Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 94
The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......
Global Zinc Oral Drops Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 85
The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030.
North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030.
Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......
Global Zinc Drops Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 85
The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030.
North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030.
Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......
Global Anti-Infectives Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 78
The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......
SERVICES
Value for Money
We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
Ever Growing Inventory
Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
One Stop Solution
Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
Dedicated Client Engagement
Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
Saving Time and Efforts
Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
Payment Flexibility
Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
Post-Purchase Research Support
Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements.
Subscription Offers & Packages (Get in touch with us for more details -
[email protected] / +1 888 391 5441 )
- Ad Hoc
-
- Pay - as - you - go / Bucket Subscriptions
- Fixed Cost for #of reports
- Customize / Personalize as per your needs